18 F-FDG PET/CT for Diagnosis of osteosclerotic and osteolytic vertebral metastatic lesions: Comparison with bone scintigraphy

Asian Spine Journal

Volumn 7, Issue 2, 2013, Pages 96-103

  Uchida, Kenzo ^a   Nakajima, Hideaki ^a   Miyazaki, Tsuyoshi ^a   Tsuchida, Tatsuro ^a   Hirai, Takayuki ^a   Sugita, Daisuke ^a   Watanabe, Shuji ^a   Takeura, Naoto ^a   Yoshida, Ai ^a   Okazawa, Hidehiko ^a   Baba, Hisatoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Metastasis; Positron emission tomography and computed tomography; Spine; Technetium Tc 99m (Sn)methylenediphosphonate

Indexed keywords

EID: 84879182331     PISSN: 19761902     EISSN: 19767846     Source Type: Journal    
DOI: 10.4184/asj.2013.7.2.96     Document Type: Article

References (29)

1. Rodriguez M, Dinapoli RP. Spinal cord compression: with special reference to metastatic epidural tumors. Mayo Clin Proc 1980;55:442-8.
2. Schiff D, O'Neill BP, Suman VJ. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach. Neurology 1997;49:452-6.
3. Bilsky MH, Lis E, Raizer J, Lee H, Boland P. The diagnosis and treatment of metastatic spinal tumor. Oncologist 1999;4:459-69.
4. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 2001;26:298-306.
5. Jocobson AF. Bone scanning in metastatic disease. In: Collier DC, Fogelman I, Rosenthall L, editors. Skeletal nuclear medicine. St. Louis, MO: Mosby; 1996. p.87-123.
6. Moog F, Kotzerke J, Reske SN. FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 1999;40:1407-13.
7. Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999;212:803-9.
8. Franzius C, Sciuk J, Daldrup-Link HE, Jurgens H, Schober O. FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 2000;27:1305-11.
9. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases. Anticancer Res 2000;20:2189-92.
10. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-79.
11. Kluetz PG, Meltzer CC, Villemagne VL, et al. Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 2000;3:223-30.
12. Kaim AH, Burger C, Ganter CC, et al. PET-CTguided percutaneous puncture of an infected cyst in autosomal dominant polycystic kidney disease: case report. Radiology 2001;221:818-21.
13. Metser U, Lerman H, Blank A, Lievshitz G, Bokstein F, Even-Sapir E. Malignant involvement of the spine: assessment by 18F-FDG PET/CT. J Nucl Med 2004;45:279-84.
14. Nakamoto Y, Cohade C, Tatsumi M, Hammoud D, Wahl RL. CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. Radiology 2005;237:627-34.
15. Kim JK, Learch TJ, Colletti PM, Lee JW, Tran SD, Terk MR. Diagnosis of vertebral metastasis, epidural metastasis, and malignant spinal cord compression: are T(1)-weighted sagittal images sufficient? Magn Reson Imaging 2000;18:819-24.
16. Kim HJ, Ryu KN, Choi WS, Choi BK, Choi JM, Yoon Y. Spinal involvement of hematopoietic malignancies and metastasis: differentiation using MR imaging. Clin Imaging 1999;23:125-33.
17. Mehta RC, Marks MP, Hinks RS, Glover GH, Enzmann DR. MR evaluation of vertebral metastases: T1-weighted, short-inversion-time inversion recovery, fast spin-echo, and inversion-recovery fast spin-echo sequences. AJNR Am J Neuroradiol 1995;16:281-8.
18. Yuh WT, Zachar CK, Barloon TJ, Sato Y, Sickels WJ, Hawes DR. Vertebral compression fractures: distinction between benign and malignant causes with MR imaging. Radiology 1989;172:215-8.
19. Resnick D. Skeletal metastasis. In: Resnick D, editor. Bone and joint imaging. Philadelphia, PA: W.B. Saunders Company; 1996. p.1076-91.
20. Hawkins RA, Hoh CK. PET bone imaging. In: Collier D, Fogelman I, Rosenthall L, editors. Skeletal nuclear medicine. St. Louis, MO: Mosby; 1996. p.435-42.
21. Cheran SK, Herndon JE, Patz EF Jr. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. Lung Cancer 2004;44:317-25.
22. Abe K, Sasaki M, Kuwabara Y, et al. Comparison of 18FDG-PET with 99mTc-HMDP scintigraphy for the detection of bone metastases in patients with breast cancer. Ann Nucl Med 2005;19:573-9.
23. Cook GJ, Houston S, Rubens R, Maisey MN, Fogelman I. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998;16:3375-9.
24. Eubank WB, Mankoff DA. Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 2005;35:84-99.
25. Fogelman I, Cook G, Israel O, Van der Wall H. Positron emission tomography and bone metastases. Semin Nucl Med 2005;35:135-42.
26. Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology 1996;199:751-6.
27. Morris MJ, Akhurst T, Osman I, et al. Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer. Urology 2002;59:913-8.
28. Galasko CS. Skeletal metastases. London: Butterwoths; 1986.
29. Clavo AC, Brown RS, Wahl RL. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med 1995;36:1625-32.